Viewing Study NCT04116151


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-12 @ 11:00 PM
Study NCT ID: NCT04116151
Status: COMPLETED
Last Update Posted: 2024-02-05
First Post: 2019-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer
Sponsor: Hospital Universitario Reina Sofia de Cordoba
Organization:

Study Overview

Official Title: Effectivenes and Safety of a Cream of Aloe Vera, Camomila and Tomillo (Alantel) for Profilaxis or Treatmment of Deratitis by Radiotheraphy in Patients With Breast Cancer
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Alantel
Brief Summary: It is intended to evaluate the effect of a marketed cream (AlantelĀ®) based on natural products at high concentrations for the preventive and curative treatment (early stages) of radiation-induced dermatitis in cancer patients. For this, an experimental, prospective, controlled clinical trial, with two parallel arms, double blind, multicentre, will be carried out in which doctors will recruit 78 patients aged 14 years or over in Primary Care consultations. more, diagnosed with cancer, and having received radiotherapeutic cancer treatment, being randomly assigned to the experimental group (cosmetic cream) or the control group (emollient and moisturizing cream). The main variable will be the incidence rate of mild post-translational dermatitis and its improvement or cure once it has been established.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: